Butterfly Network to Present at UBS Global Healthcare Conference
Butterfly Network, Inc. announced its participation in the upcoming UBS Global Healthcare Conference scheduled for November 10, 2026.
Stocks · News reference
Analysts initiate coverage: Buy on Nautilus ($3.50) and SpaceX ($200); Outperform on FuelCell ($24) and Butterfly ($15); Market Perform on O’Reilly ($94).
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Butterfly Network, Inc. announced its participation in the upcoming UBS Global Healthcare Conference scheduled for November 10, 2026.
A class action lawsuit has been filed against FuelCell Energy, Inc. for allegedly making false and misleading statements regarding its manufacturing capacity, production rates under a capital equipment purchase agreement with Fit Energy, and resulting higher costs. Investors who purchased FCEL securities between June 24, 2026 and September 1, 2026 have until November 10, 2026 to apply as lead plaintiff.
FuelCell Energy, Inc. has appointed Peter Hopper to its board of directors to leverage his expertise in digital infrastructure and investment.
FuelCell Energy Inc (NASDAQ: FCEL) stock advanced on Monday amid a broad clean energy rebound led by Bloom Energy Corp (NYSE: BE).
Bloom Energy stock fell 11.24% on October 23, 2026, despite reporting record Q3 revenue with 138% year-over-year growth and raising full-year guidance. Investors sold off shares due to concerns over negative free cash flow of $181 million for the quarter and heavy capital spending needs for production expansion. The stock has declined 44% from its recent high but remains up 122% for the year.
Nautilus Biotechnology announced its financial results for the third quarter ended September 30, 2026, reporting a net loss of $15.6 million.